Heart Failure Clinical Trial
— MultiVADOfficial title:
Multidisciplinary Ventricular Assist Device Clinic: Feasibility Pilot Study and Quality of Life Impact Assessment
Verified date | May 2022 |
Source | Massachusetts General Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Current standard of care for ventricular-assist device (VAD) patients is composed of a multidisciplinary team (MDT), which is required in pre-implant and implant hospitalization care but is lacking in post-implant care. Post-implant care is currently centered around the avoidance of complications of VAD support, including cerebrovascular insult (CVA/TIA), gastrointestinal bleeding and infection. Despite major improvements in survival for VAD patients, quality of life and physical functioning measures have not seen significant improvements. This study will include two prospective interventional cohorts and a retrospective control cohort. The first prospective interventional cohort will consist of patients who recently underwent LVAD implantation at Massachusetts General Hospital, and their caregivers. These patients will receive only multidisciplinary team care from the time of their implant. The second prospective interventional cohort will consist of patients who have previously undergone LVAD implantation at Massachusetts General Hospital who are being followed-up with standard-of-care VAD clinic visits, and their caregivers. These patients will receive a hybrid of multidisciplinary team care and standard-of-care visits. The historical control cohort will consist of retrospective data collection on patients who have undergone LVAD implantation in the past and no longer have an LVAD implanted (due to transplant, death, explant, etc.), and will be matched with the prospective interventional patients. The purpose of this study is to characterize the impact of routine MDT care on health-related quality of life, caregiver burnout and functional capacity of outpatient VAD patients, and to determine if implementation of MDT care is associated with a reduction in complications and readmissions in VAD patients at one- and two-years post implant. The investigators hypothesize that the MDT clinic model in addition to standard of care VAD management will positively impact the quality of life and functional status of VAD patients. Subjects who consent to this study will be seen by the MDT providers and complete Cardiopulmonary Exercise Tests (CPET), six-minute-walk-tests, and quality of life questionnaires. The primary caregivers of these subjects will complete a Caregiver Self-Assessment at two timepoints. We anticipate to enroll 20 newly-implanted VAD patients in the pure-MDT arm, 35 pre-existing VAD patients in hybrid-MDT/SOC arm, and 55 primary caregivers.
Status | Enrolling by invitation |
Enrollment | 110 |
Est. completion date | May 2024 |
Est. primary completion date | May 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria for Group A (newly-implanted): - Ages 18+ - Individuals with ventricular assist device (VAD) implanted - Individuals who have not previously attended standard-of-care VAD follow-up clinic visits Exclusion Criteria for Group A: - Inability to answer quality of life questionnaires - Inability to perform the 6-minute walk test and Cardiopulmonary Exercise Test (CPET) - Individuals who have previously attended standard-of-care VAD follow-up clinic visits Inclusion Criteria for Group B (previously-implanted): - Ages 18+ - Individuals with ventricular assist device (VAD) implanted - Individuals who have previously attended standard-of-care VAD follow-up clinic visits Exclusion Criteria for Group B: - Inability to answer quality of life questionnaires - Inability to perform the 6-minute walk test and CPET |
Country | Name | City | State |
---|---|---|---|
United States | Massachusetts General Hospital | Boston | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Massachusetts General Hospital |
United States,
Tractenberg RE, Yumoto F, Aisen PS. Detecting When "Quality of Life" Has Been "Enhanced": Estimating Change in Quality of Life Ratings. Open J Philos. 2013 Nov 1;3(4A):24-31. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Peak VO2 in mL/kg of body weight/min during Cardiopulmonary Exercise Test | Retrospective review in a patient chart. | Change from pre-implant peak VO2 at 12 months post LVAD implantation | |
Primary | Respiratory Exchange Ratio (RER) in % during Cardiopulmonary Exercise Test | Retrospective review in a patient chart. | Change from pre-implant RER at 12 months post LVAD implantation | |
Primary | Minute ventilation per carbon dioxide production (VE/VCO2) during Cardiopulmonary Exercise Test | Retrospective review in a patient chart. | Change from pre-implant VE/VCO2 at 12 months post LVAD implantation | |
Primary | Blood pressure in mmHg during Cardiopulmonary Exercise Test | Retrospective review in a patient chart. | Change from pre-implant blood pressure at 12 months post LVAD implantation | |
Primary | Heart rate in beats per minute during Cardiopulmonary Exercise Test | Retrospective review in a patient chart. | Change from pre-implant heart rate at 12 months post LVAD implantation | |
Primary | EuroQoL (EQ-5D and EuroVAS) to measure quality of life | Survey administered by research coordinator | Change from pre-implant up to 12 months post LVAD implantation | |
Primary | Kansas City Cardiomyopathy Questionnaire (KCCQ) to measure quality of life | Survey administered by research coordinator | Change from pre-implant up to 12 months post LVAD implantation | |
Primary | Montreal Cognitive Assessment (MoCA) to measure cognitive function | Assessment administered by Occupational Therapist | Change from pre-implant up to 12 months post LVAD implantation | |
Secondary | Number of readmissions | Retrospective review in a patient chart | up to 24 months post-LVAD implantation | |
Secondary | Time to readmission in days | Retrospective review in a patient chart | up to 24 months post-LVAD implantation | |
Secondary | Number of VAD related complications | Retrospective review in a patient chart for GI bleed, CVA, heart failure, and infection | up to 24 months post-LVAD implantation |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05196659 -
Collaborative Quality Improvement (C-QIP) Study
|
N/A | |
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Active, not recruiting |
NCT05896904 -
Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction
|
N/A | |
Completed |
NCT05077293 -
Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
|
||
Recruiting |
NCT05631275 -
The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
|
||
Enrolling by invitation |
NCT05564572 -
Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology
|
N/A | |
Enrolling by invitation |
NCT05009706 -
Self-care in Older Frail Persons With Heart Failure Intervention
|
N/A | |
Recruiting |
NCT04177199 -
What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
|
||
Terminated |
NCT03615469 -
Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY)
|
N/A | |
Recruiting |
NCT06340048 -
Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure
|
Phase 1/Phase 2 | |
Recruiting |
NCT05679713 -
Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
|
||
Completed |
NCT04254328 -
The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure
|
N/A | |
Completed |
NCT03549169 -
Decision Making for the Management the Symptoms in Adults of Heart Failure
|
N/A | |
Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
Enrolling by invitation |
NCT05538611 -
Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
|
||
Recruiting |
NCT04262830 -
Cancer Therapy Effects on the Heart
|
||
Completed |
NCT06026683 -
Conduction System Stimulation to Avoid Left Ventricle Dysfunction
|
N/A | |
Withdrawn |
NCT03091998 -
Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support
|
Phase 1 | |
Recruiting |
NCT05564689 -
Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy
|